Sunbeam Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$299K Buy
827
+24
+3% +$8.22K 0.14% 99
2026
Q1
$282K Buy
803
+14
+2% +$4.99K 0.16% 87
2025
Q4
$258K Buy
789
+12
+2% +$3.81K 0.15% 91
2025
Q3
$219K Buy
+777
New +$225K 0.14% 94

Other funds holding AMGN

Sunbeam Capital Management's AMGN Position: Q2 2026 in Review

Sunbeam Capital Management increased its Amgen (AMGN) stake by 3% in Q2 2026, buying an estimated $8.22K and bringing the position to 827 shares worth $299K. The position accounts for 0.14% of the portfolio, ranked #99.

Sunbeam Capital Management first reported a position in AMGN in Q3 2025 and has held it in 4 quarters since. 1,540 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sunbeam Capital Management held 827 shares of Amgen worth $299K as of Q2 2026.
  • Sunbeam Capital Management bought 24 Amgen shares in Q2 2026, an estimated $8.22K.
  • Amgen made up 0.14% of Sunbeam Capital Management's portfolio in Q2 2026, its #99 holding.
  • Sunbeam Capital Management first reported a position in Amgen in Q3 2025 and has held it in 4 quarters since.
  • 1,540 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sunbeam Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.